Coronavirus disease 2019 in a 2-month-old male infant: a case report from Iran

Heydari, Hassan; Hossaini, Seyed Kamal Eshagh; Hormati, Ahmad; Afifian, Mahboubeh; Ahmadpour, Sajjad

doi:10.3345/cep.2020.00941

Search citation statements

Order By: Relevance

Paper Sections

Select...

Covid-19 and All1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It has been well documented that definitive diagnosis of COVID-19 in children is less than 2%. Relatively few pediatric COVID-19 cases were hospitalized, as mainly limited to the pediatric patients aged <1 year and those with underlying conditions [ 2 , 3 ]. ALL numerate as the most common form of childhood malignancy that originates in a single B- or T-lymphocyte progenitor.…”

Section: Covid-19 and Allmentioning

confidence: 99%

Coronavirus disease 2019 in a 13-year-old patient with acute lymphoblastic leukemia

et al. 2021

Self Cite

View full text Add to dashboard Cite

What should be considered in an immunocompromised child with coronavirus disease (COVID-19)? Finding: Due to the importance of appropriately managing COVID-19 in children with cancer, the possibility of a fatal outcome should be considered in immunocompromised patients who receive chemotherapy agents. Meaning: In all kinds of infections including COVID-19, disuse management and the development of international guidelines for children with cancer is challenging but important.

show abstract

Section: Covid-19 and Allmentioning

confidence: 99%